Abstract 780: An EGFR inhibitor enhances the efficacy of SN38, an active metabolite of irinotecan, in SN38-refractory gastric carcinoma cells
暂无分享,去创建一个
T. Sawada | M. Yashiro | K. Hirakawa | K. Maeda | M. Ohira | Xiaotian Zhang | Hiroaki Tanaka | Katsunobu Sakurai | N. Kubo | T. Hasegawa | T. Morisaki | H. Qiu | N. Yamada | N. Aomatsu | Toshiki Hirakawa | T. Fukuoka